SOURCE: Aesculap

Aesculap

June 18, 2013 14:59 ET

Aesculap Implant Systems Introduces the New CeSpace™XP Cervical Interbody System

The CeSpaceXP Is an Optimum Fusion of the Osteoconductive Plasmapore®XP Coating and PEEK-Optima®* Core for Enhanced Implant Stability, Artifact-Free Imaging, and an Ideal Scaffold for ACDF Procedures

CENTER VALLEY, PA--(Marketwired - June 18, 2013) -  Aesculap Implant Systems recently introduced the CeSpaceXP Interbody System for ACDF procedures. The CeSpaceXP fuses two proven materials, an innovative Plasmapore®XP osteoconductive porous Titanium coating and a PEEK-Optima® radiolucent core, that deliver enhanced implant stability, artifact-free imaging, and an optimal scaffold for cervical fusion procedures. A comprehensive range of instrument and implant-options are available to accommodate varying patient anatomies and intraoperative needs.

The design advantages of the CeSpaceXP are the result of over 30 years of innovation in spinal technology and over 20 years of success in applying Plasmapore® coatings to Titanium orthopedic and spine implants. Drawing on the success of Plasmapore, Aesculap developed PlasmaporeXP, an osteoconductive porous Titanium coating that can be applied to PEEK spinal implants. PlasmaporeXP is an innovative surface enhancing technology with proven biocompatibility.1

The CeSpaceXP implant brings the market a distinctive interbody design for ACDF procedures. The CeSpaceXP enhances stability and increases migration resistance through the roughened surface area provided by the PlasmaporeXP coating. The CeSpaceXP offers a comprehensive selection of easy-to-use instrumentation and 30 size options to ensure the best possible fit to patient anatomy and intraoperative flexibility. The CeSpaceXP has excellent imaging properties, incorporating the benefits of the PlasmaporeXP coating, which clearly delineates implant contours during imaging, with X-Ray marker pins for intraoperative positioning and verification.1

Bob Spiro, PhD, Vice President of Aesculap Biologics and expert in immunology and tissue regeneration, said, "The PlasmaporeXP coating found on the CeSpaceXP implant provides the ideal surface composition and architecture for direct bone contact, resulting in higher mechanical strength and improved implant stability."

The CeSpaceXP is an interbody fusion device designed for use with autogenous bone graft and intended for spinal fusion procedures at one level in the cervical spine from C3 - C7.

Visit www.aesculapimplantsystems.com/CeSpaceXP to view the product animation and complete product information.

References:

1 Data on file
 *PEEK-Optima is registered trademark of Invibio Biomaterial Solutions.

About Aesculap Implant Systems, LLC
Aesculap Inc., a B. Braun company, founded in 1867 in Tuttlingen, Germany, is the world's largest and one of the most respected manufacturers of surgical instruments and sterilization container. Aesculap is a leading privately-owned manufacturing company, passionately committed to providing high-quality, innovative products and services to all surgical disciplines, with particular focus in the fields of General, Neuro, Spine and Orthopaedics.

Aesculap Implant Systems, LLC, established by Aesculap, Inc. in 2005, focuses on delivering innovative solutions to the spine and orthopaedic markets. Aesculap Implant Systems maintains a surgeon/patient focus with the goal of improved operative procedures and patient outcomes leading to an improved quality of life. For more information about Aesculap Implant Systems or its medical products, call 800-234-9179, email us at info@aesculap.com or visit www.AesculapImplantSystems.com.

About B. Braun
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun group of companies includes B.Braun, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania, with its global headquarters based in Melsungen, Germany. It employs more than 44,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.bbraunusa.com.

The following files are available for download:

Contact Information

  • Contact information
    Dana Burns
    Aesculap, Inc.
    phone: 610-984-9242
    mobile: 610-217-4964
    email: dana.burns@aesculap.com
    twitter: @dburns_comm